Annual Report 2022

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2022 104 The United Laboratories International Holdings Limited Annual Report 2022 14. FIVE HIGHEST PAID EMPLOYEES For the years ended 31 December 2022 and 2021, all the five highest paid individuals of the Group are directors of the Company, details of which are included in Note 13. 15. DIVIDENDS 2022 2021 RMB’000 RMB’000 Dividends for ordinary shareholders of the Company recognised as distribution during the current year – 2022 interim dividend RMB5 cents (2021: 2021 interim dividend RMB4 cents) per share 90,879 73,616 – 2021 final dividend RMB8 cents (2021: 2020 final dividend RMB8 cents) per share 145,406 147,231 – 2021 special dividend RMB2 cents (2021: nil) per share 36,351 – 272,636 220,847 Subsequent to the end of the reporting period, a final dividend of RMB14 cents (2021: RMB8 cents) per ordinary share and a special dividend of RMB6 cents (2021: RMB2 cents) per ordinary share in respect of the year ended 31 December 2022, in an aggregate amount of RMB363,405,000 (2021: RMB181,757,000), has been proposed by the directors of the Company and is subject to approval by the shareholders in the forthcoming annual general meeting.